Forte Biosciences, Inc.

Reported to SECin USCIK 0001419041Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 68. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 68
Form 4 lines at Forte Biosciences, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Kapoor Shivpreet Singh—Returned to the issuer—18,353 sharesAug 27, 2026Kapoor Shivpreet Singh—Returned · Aug 27Returned to the issuer18,353Aug 27, 2026
Kapoor Shivpreet Singh—Returned to the issuer—31,000 sharesAug 27, 2026Kapoor Shivpreet Singh—Returned · Aug 27Returned to the issuer31,000Aug 27, 2026
Kapoor Shivpreet Singh—Returned to the issuer—2,000 sharesAug 27, 2026Kapoor Shivpreet Singh—Returned · Aug 27Returned to the issuer2,000Aug 27, 2026
Brun Scott C.—Returned to the issuer—18,353 sharesAug 27, 2026Brun Scott C.—Returned · Aug 27Returned to the issuer18,353Aug 27, 2026
Brun Scott C.—Returned to the issuer—31,000 sharesAug 27, 2026Brun Scott C.—Returned · Aug 27Returned to the issuer31,000Aug 27, 2026